Call Us Contact Us
+44 1494 818 000     Online Enquiry
Lines open
Monday to Thursday
08:30 to 18:00
08:30 to 17:30
Pharmaceutical | Medical Devices | Scientific | Consumer Healthcare | Dental | Animal Health
Healthcare Communications | Pharmaceutical Executive | Medical Executive | Tech PR | Scientific Executive
Latest Jobs
Exclusive vacancies may not be shown here, please contact Laura on +44 1494 818 026 or for more information.
Have you registered?
Once you register you can see additional job details, save jobs, track your applications and manage e-lert preferences.

Register now
Laura Marsh
Account Manager
+44 1494 818 026

I have nothing but very positive words to say about my experiences working with Zenopa, who have recently recruited me into a new role.
Paul, 2011

Bristol-Myers Squibb funds Asian hepatitis initiatives

21 February 2011 00:00 in Pharmaceutical Company Product News

Bristol-Myers Squibb has provided funding to support a number of schemes dedicated to combating hepatitis B and C in China and India.

Via the independent charitable body the Bristol-Myers Squibb Foundation, the company is providing four new grants worth nearly $1 million (616,285 pounds) to help improve understanding and care quality in underprivileged areas.

China's Wu Jieping Medical Foundation will use the contribution to conduct a study of the impact of hepatitis C in the country, which will be used to inform future health policy.

Meanwhile, in India the Health Oriented Programmes and Education scheme, the Hepatitis Foundation of Tripura and the United Way Mumbai initiative will all benefit from funding, allowing them to conduct awareness and vaccination campaigns.

John Damonti, president of the Bristol-Myers Squibb Foundation, said: "We look forward to improved hepatitis awareness, prevention and care in these countries' communities, as well as to applying our key learnings from these programmes in other countries."

Last month, Bristol-Myers Squibb published its financial results for the final quarter of 2010, reporting a two percent year-on-year increase in sales.ADNFCR-8000103-ID-800416673-ADNFCR

Other news stories from 21/02/2011

Related news

Read more in the Zenopa News Archive

How this news is generated

Story collated for Zenopa by the Axonn News Agency

© Copyright 2015 Zenopa Ltd